Videx EC 125 mg gastro-resistant hard capsules
- Licence status
- Withdrawn: 30/08/2019
- Active substances
- Didanosine
- Dosage Form
- Gastro-resistant capsule
- Licence number
- PA0002/057/016
- Licence holder
- Bristol-Myers Squibb Pharmaceuticals uc
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors, J05AF02 didanosine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 15/09/2000